Defining the null hypothesis

Area of Science:

• Virology
• Pharmacology
• Infectious Diseases

Background:

• Virus B is a novel viral strain with no existing treatments.
• Drug A has been identified as a potential therapeutic agent against Virus B.
• Pre-clinical studies are essential to evaluate the efficacy of new drug candidates.

Purpose of the Study:

• To assess the efficacy of Drug A in improving survival rates of mice infected with Virus B.
• To determine if Drug A can mitigate mortality caused by Virus B infection in a pre-clinical model.

Main Methods:

• A pre-clinical study was conducted using a mouse model infected with Virus B.
• Mice were divided into groups: control, Virus B-infected without treatment, and Virus B-infected with Drug A treatment.
• Survival rates between groups were compared using statistical analysis (z-test for proportions).

Main Results:

• A significant difference in survival was observed between Virus B-infected mice without treatment and control mice (P < 0.05).
• No significant difference in survival was found between Drug A-treated, Virus B-infected mice and control mice.
• The study involved 30 mice per group (n = 30).

Conclusions:

• Drug A demonstrated effectiveness in reducing mouse mortality associated with Virus B infection.
• The findings suggest Drug A holds potential as a treatment for Virus B.
• Further research is warranted to explore Drug A's therapeutic application for Virus B.